methylethyl(silatrane-1-ylmethyl)sulfonium has been researched along with Aortic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuznetsov, IG; Rasulov, MM; Sorokin, MS; Voronkov, MG | 1 |
1 other study(ies) available for methylethyl(silatrane-1-ylmethyl)sulfonium and Aortic Diseases
| Article | Year |
|---|---|
[Methylethyl(silatran-1-ylmethyl)sulfonium iodide--an inhibitor of the development of experimental atherosclerosis of the aorta].
Topics: Animals; Aortic Diseases; Arteriosclerosis; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Citrates; Citric Acid; Drug Synergism; Hydrolysis; Lipids; Rabbits; Salicylates; Silicon; Sulfonium Compounds | 1989 |